RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 118 filers reported holding RELMADA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $591,591 | -21.1% | 197,197 | -35.3% | 0.00% | 0.0% |
| Q2 2023 | $750,020 | -17.9% | 304,886 | -24.6% | 0.00% | -33.3% |
| Q1 2023 | $913,661 | -50.3% | 404,275 | -23.3% | 0.00% | -50.0% |
| Q4 2022 | $1,839,795 | -4.2% | 527,162 | +916.0% | 0.01% | -14.3% |
| Q3 2022 | $1,921,000 | +789.4% | 51,888 | +357.1% | 0.01% | +600.0% |
| Q2 2022 | $216,000 | -23.7% | 11,351 | +8.1% | 0.00% | 0.0% |
| Q1 2022 | $283,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |